You will note, you question was about this technology.
"So IVX are developing this technology for another company (and that company is paying the R&D costs)."
Recent news:". The activity of Invion during the period was directed to the development of the Photosoft™ technology for the treatment of a range of cancers. Invion has been appointed exclusive licensee in Australia and New Zealand of the Photosoft™ technology"
This technology is for more than cancer treatment.
For cancer treatment only - yes, Aust and NZ.
For others, Asia Pacific region (with exclusions).
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)